IgA Nephropathy from the VALIGA European Study: Differences in Treatment Approaches Within Europe

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2.4 (16 votes)

This article have been viewed 1884 times

Buy Membership for Nephrology Category to continue reading. Learn more here

Related posts:

Default ThumbnailBeyond the Differences in Tonsillectomy in IgA Nephropathy: From Rationale To Indications in Patients Differences of Histological Classification Between the Japanese Histological Grade Classification and the Oxford Classification Is Tonsillectomy a Possible Treatment for IgA Nephropathy from Randomized Controlled Trial (RCT)? Japanese Clinical Practice Guidelines for IgA Nephropathy: Difference from KDIGO Guidelines Complement Activation Prognostic Indicators and Treatment of IgA Nephropathy in China